To this end, the incidence of germline pathogenic BRCA variants in pancreatic cancer was described with a prevalence ranging from 0.3–2.3% for BRCA1 and 0.7–5.7% for BRCA2 [47]. This evidence concerns the gene BRCA1 and familial pancreatic carcinoma.